28 participants
Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-11-28
- Start Date:
- 2022-07-18
- Completion:
- 2023-07-02
Conditions
- Locally Advanced Gastric Adenocarcinoma
Interventions
- DRUG
No Results Yet